Rani Therapeutics Holdings, Inc. Quarterly Interest Expense in USD from Q2 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Rani Therapeutics Holdings, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q4 2024.
  • Rani Therapeutics Holdings, Inc. Interest Expense for the quarter ending December 31, 2024 was $1.13M, a 13.1% decline year-over-year.
  • Rani Therapeutics Holdings, Inc. Interest Expense for the twelve months ending December 31, 2024 was $5.03M, a 1.02% decline year-over-year.
  • Rani Therapeutics Holdings, Inc. annual Interest Expense for 2024 was $5.03M, a 1.02% decline from 2023.
  • Rani Therapeutics Holdings, Inc. annual Interest Expense for 2023 was $5.09M, a 375% increase from 2022.
  • Rani Therapeutics Holdings, Inc. annual Interest Expense for 2022 was $1.07M, a 130% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $5.03M $1.13M -$170K -13.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $5.2M $1.34M +$21K +1.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $5.18M $1.28M +$10K +0.79% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $5.17M $1.29M +$87K +7.21% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $5.09M $1.3M +$577K +80.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $4.51M $1.32M +$964K +274% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $3.54M $1.27M +$1.27M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $2.28M $1.21M +$1.21M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $1.07M $719K +$720K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $351K $352K +$242K +220% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $109K $0 -$169K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $278K $0 -$188K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $466K -$1K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $110K +$46K +71.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $169K +$167K +8350% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $188K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $64K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-16
Q2 2020 $2K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.